ArticleIrish journal of medical science2026

FDA Approval of daratumumab and hyaluronidase-fihj plus vrd for the frontline treatment of newly diagnosed multiple myeloma.

Laiba Riaz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.